跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lezure - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lezure
Approved
STANDARD
Lezure
Hetero Labs Limited (Unit III)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c03b66fd9f733139
Company
Hetero Labs Limited (Unit III)
Type
Standard
Approval Details
Approval Id
c03b66fd9f733139
Drug Approval Philippines Name
Lezure
Product Name
Lezure
Registration Number
DRP-9033
Brand Name
Lezure
Generic Name
Levetiracetam
Dosage Form
Oral Solution
Dosage Strength
100 mg/mL
Manufacturer
Hetero Labs Limited (Unit III)
Importer
Camber Pharmaceuticals, Inc
Distributor
Camber Pharmaceuticals, Inc
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
26 April 2025
Expiry Date
20 August 2031
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c03b66fd9f733139
Type
Standard
Back to Philippines FDA Approvals